SGLT2 inhibitors show modest, uncertain benefit for functional mitral regurgitation
A meta-analysis of three randomized trials found modest reductions in functional mitral regurgitation with SGLT2 inhibitors, but fragile results and ...
A meta-analysis of three randomized trials found modest reductions in functional mitral regurgitation with SGLT2 inhibitors, but fragile results and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.